Financial Press Releases

  • 02/07/2021 ore 09:22
    FRIULCHEM COMPLETES THE ACQUISISTION OF A PRODUCTION SITE LOCATED IN MAGNY-EN-VEXIN FROM VIRBAC S.A., A FRENCH VETERINARY COMPANY
  • 17/06/2021 ore 17:47
    FRIULCHEM CONFIRMS TO CFO SIM S.P.A. THE ROLE OF SPECIALIST THAT TAKES OVER INTEGRAE SIM S.P.A. FROM 26 JULY 2021. CFO SIM S.P.A. HE WILL CARRY OUT BOTH NOMAD AND SPECIALIST ROLES FOR FRIULCHEM
  • 25/05/2021 ore 12:13
    FRIULCHEM PARTECIPA ALLA “AIM ITALIA CONFERENCE 2021"
  • 24/05/2021 ore 07:51
    FRIULCHEM FIRMA UN ACCORDO PRELIMINARE VINCOLANTE PER L’ACQUISTO DI UN RAMO DI AZIENDA PRODUTTIVO IN FRANCIA
  • 19/05/2021 ore 17:18
    CFO SIM S.P.A. HA RILASCIATO A BORSA ITALIANA LE DICHIARAZIONI DELLA SCHEDA 2, SEZIONE C DEL REGOLAMENTO NOMINATED ADVISERS. CFO SIM SUBENTRA NEL RUOLO DI NOMAD DAL 24 MAGGIO 2021
  • 13/05/2021 ore 17:57
    FRIULCHEM CONFERISCE A CFO SIM IL RUOLO DI NOMAD CHE SUBENTRA A INTEGRAE SIM S.P.A. DAL 24 MAGGIO 2021
  • 12/05/2021 ore 17:35
    FRIULCHEM APPROVA LA DELIBERA QUADRO INERENTE AL CONTRATTO DI FORNITURA DI MATERIE PRIME CON EVULTIS
  • 26/04/2021 ore 20:08
    Revoca incarico specialist
  • 23/04/2021 ore 17:19
    Friulchem: Ordinary and straordinary Shareholders' Meeting approves the Financial Statements as at 31 December 2020
  • 24/03/2021 ore 18:00
    Friulchem: approvato il progetto di bilancio al 31 dicembre 2020
  • 27/01/2021 ore 16:12
    2021 corporate events calendar
  • 03/12/2020 ore 07:58
    Friulchem da inizio 2021 sbarca sul mercato degli additivi per mangimi destinati agli animali da reddito con la commercializzazione in Italia di una linea propria
  • 30/11/2020 ore 17:30
    Warrant Friulchem S.p.A. 2019-2022” - ISIN IT0005378366 - Chiusura del primo periodo di esercizio 2-30 novembre 2020
  • 02/11/2020 ore 10:40
    Friulchem sarà tra i protagonisti della Virtual Investors Conference “NEXT GEMS”
  • 30/10/2020 ore 08:32
    Primo periodo esercizio warrant
  • 24/09/2020 ore 18:31
    Consiglio di Amministrazione di Friulchem: approva la relazione semestrale al 30 giugno 2020
  • 24/07/2020 ore 09:44
    FRIULCHEM: NOTIFICATO A CONSOB L’AGGIORNAMENTO DEL KID
  • 06/07/2020 ore 09:41
    Friulchem ottiene in Francia l’autorizzazione per un’estensione del brevetto legato alle compresse masticabili FC-CUBES
  • 08/05/2020 ore 09:56
    Friulchem: riconosciuto credito di imposta su costi di IPO per € 339 mila
  • 30/04/2020 ore 19:12
    Il Consiglio di Amministrazione di Friulchem: approva la delibera quadro inerente al contratto di fornitura di materie prime con Evultis e attribuisce deleghe al consigliere Carlo Marelli
  • 23/04/2020 ore 17:32
    Friulchem: Ordinary Shareholders' Meeting approves the Financial Statements as at 31 December 2019
  • 24/03/2020 ore 17:59
    Friulchem: draft financial statements as at 31 December 2019 approved
  • 23/03/2020 ore 12:31
    Coronavirus covid-19 emergency: Friulchem is continuing with production activities
  • 11/03/2020 ore 11:58
    Friulchem grows in the USA and continues its internationalisation process with the acquisition of 13% of Pharmabbie Inc, American company specialised in the development of veterinary drugs to be administered with Friulchem’s FC-CUBE® technology
  • 25/02/2020 ore 17:43
    Friulchem approves the framework resolution regarding the raw materials supply contract with Evultis
  • 20/01/2020 ore 17:05
    2020 Company events calendar
  • 13/12/2019 ore 16:53
    Friulchem approves the transaction with related party
  • 28/11/2019 ore 17:55
    Friulchem approves the framework resolution concerning the contract for the supply of raw materials with Evultis
  • 15/10/2019 ore 07:15
    Friulchem obtains authorization for the marketing in South Africa of an antibiotic for human use with a wide spectrum of action for serious infections

    Friulchem S.p.A. (AIM: FCM), announces that it has obtained, after a "registration process" of over 5 years, the authorization for the marketing in South Africa of a broad-spectrum antibiotic for human use (injectable betalactam belonging to the class of carbapenems for the treatment of serious infections) and to have entered into an agreement with a leading multinational pharmaceutical company - world leader in the distribution of generic drugs - for exclusive distribution in South Africa.

  • 27/09/2019 ore 18:47
    Friulchem continues its internationalization process with the establishment of Friulchem USA Inc.

    Friulchem S.p.A. (AIM: FCM) communicates the constitution of the Friulchem USA Inc. company. The newly company will be active in the marketing and distribution of feed supplement or non-pharmaceutical products for the North American veterinary sector.

  • 27/09/2019 ore 09:30
    CEO at the 2019 semi-annual report

    Disma Giovanni Mazzola, CEO of Friulchem S.p.A. (AIM: FCM) commented on the 2019 half-year figures

  • 26/09/2019 ore 17:55
    Friulchem: the half-year report as of June 30, 2019 approved
  • 29/07/2019 ore 17:58
    SIGNIFICANT SHAREHOLDERS (Available only in Italian)
  • 25/07/2019 ore 18:01
    CORPORATE EVENTS CALENDAR 2019 (Available only in Italian)
  • 23/07/2019 ore 18:37
    NOTIFIED TO CONSOB THE KID - "KEY INFORMATION DOCUMENT" CONCERNING THE "WARRANT FRIULCHEM 2019-2022"
  • 23/07/2019 ore 16:25
    FRIULCHEM S.p.A. ADMITTED TO TRADING ON THE AIM ITALIA MARKET